How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Calcium Acetate (Cas 62-54-4) Market
- By Application: Pharmaceuticals (Phosphate Binder), Food Additive (Preservative, Flavor Enhancer), Chemical Intermediate, Animal Feed Additive, Water Treatment
- By Form: Powder, Granules, Crystals
- By Purity Grade: Food Grade, Pharmaceutical Grade, Industrial Grade
- By End-Use Industry: Healthcare, Food & Beverage, Agriculture, Water Treatment, Chemical Manufacturing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Pharmaceuticals (Phosphate Binder) leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 270 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.164 →
- 11 Company Profiles 14 players: SWOT & benchmarking p.172 →
Full report · locked preview
Everything inside the Calcium Acetate (Cas 62-54-4) Market report
A complete, evidence-based study - 11 chapters and 113 sections covering market size, segmentation across 4 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Evonik Industries AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Jiangsu Jiuding New Material Technology Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Shandong Xinhua Pharmaceutical Company Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Changzhou Qianhong Chemical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Zhejiang Tianyi Chemical Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Jiangsu Huachang Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Lianyungang Huasheng Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hebei Yatai Pharmaceutical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Wuhan Yuancheng Gongchuang Technology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Jiangsu Yonghua Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Shandong Xinhua Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Zhejiang Huafeng Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Jiangsu Tianhe Pharmaceutical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Pharmaceuticals (Phosphate Binder)37.4
- Food Additive (Preservative, Flavor Enhancer)16.1
- Chemical Intermediate14.9
- Animal Feed Additive16.4
- Water Treatment15.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE24.9
- Evonik Industries AG23.6
- Jiangsu Jiuding New Material Technology Co. Ltd.5.2
- Shandong Xinhua Pharmaceutical Company Limited4.7
- Changzhou Qianhong Chemical Co. Ltd.6.7
- Zhejiang Tianyi Chemical Co. Ltd.6.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.7
- Europe21.0
- Asia Pacific20.4
- Latin America13.3
- Middle East and Africa10.5
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 77 | 84 | 92 | 98 | 74 | 83 | 85 |
| Evonik Industries AG | 89 | 92 | 87 | 68 | 90 | 70 | 83 |
| Jiangsu Jiuding New Material Technology Co. Ltd. | 76 | 80 | 88 | 72 | 63 | 87 | 78 |
| Shandong Xinhua Pharmaceutical Company Limited | 77 | 76 | 82 | 67 | 76 | 66 | 74 |
| Changzhou Qianhong Chemical Co. Ltd. | 74 | 63 | 70 | 52 | 63 | 65 | 65 |
| Zhejiang Tianyi Chemical Co. Ltd. | 60 | 68 | 71 | 47 | 54 | 61 | 60 |
| Jiangsu Huachang Chemical Co. Ltd. | 55 | 61 | 57 | 65 | 48 | 50 | 56 |
| Lianyungang Huasheng Chemical Co. Ltd. | 44 | 50 | 57 | 60 | 37 | 49 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Evonik Industries AG
- Jiangsu Jiuding New Material Technology Co. Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Evonik Industries AG | ◐ | ✓ | ◐ | − | ✓ | ✓ |
| Jiangsu Jiuding New Material Technology Co. Ltd. | ✓ | ✓ | ✓ | ✓ | − | ✓ |
| Shandong Xinhua Pharmaceutical Company Limited | ◐ | ✓ | ✓ | ◐ | ✓ | − |
| Changzhou Qianhong Chemical Co. Ltd. | ✓ | − | ◐ | ◐ | ◐ | ◐ |
| Zhejiang Tianyi Chemical Co. Ltd. | ◐ | ◐ | ✓ | − | ◐ | ◐ |
| Jiangsu Huachang Chemical Co. Ltd. | − | ◐ | ◐ | ✓ | − | ◐ |
| Lianyungang Huasheng Chemical Co. Ltd. | − | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Challenger1
Strong scale, closing on the leaders.
Contender2
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Application in North America, then scale across Calcium Acetate (Cas 62-54-4) Market — a $198M beachhead inside a $3.31B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Pharmaceuticals (Phosphate Binder)
Best fit — highest urgency & budget in Application.
Food Additive (Preservative, Flavor Enhancer)
Strong fit — clear ROI and a fast path to value.
Chemical Intermediate
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Purity Grade
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Calcium Acetate (Cas 62-54-4) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Calcium Acetate (Cas 62-54-4) Market is a resilient opportunity — $3.31B by 2033, compounding at 5.1%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.1% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Calcium Acetate (Cas 62-54-4) Market — a $610M market by 2033. Plan: grow share from 5.8% to 11.8%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.8% | 11.8% | Behind |
| Revenue | $34M | $72M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Ahead |
| Gross margin | 32.9% | 40.5% | Behind |
| Customer retention | 88.8% | 92.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $10M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Calcium Acetate (Cas 62-54-4) Market conversation — a $4.66B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Calcium Acetate (Cas 62-54-4) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Calcium Acetate (Cas 62-54-4) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Calcium Acetate Dihydrate Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportCalcium Acetate Hydrate (114460-21-8) Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportCalcium Acetate Monohydrate (5743-26-0) Market
Market size, share, segmentation and regional forecast.
$866M market · 2025 base year
View reportCalcium Alginate Dressing for Medical Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportCalcium Aluminum Grease Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportCalcium ascorbate dihydrate CAS 5743-28-2 Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCalcium Borate Nanoparticles Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportCalcium Borate Phosphate Market
Market size, share, segmentation and regional forecast.
$318M market · 2025 base year
View reportCalcium Borate Silicate Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportCalcium Borate Stone Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportCalcium Borosilicate Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCalcium Bromide Brine Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy